Access
To read this article in full you will need to log-in or choose from the options on the right.
Targets and Mechanisms - Neurology
SciBX 1(39); doi:10.1038/scibx.2008.939
Published online Oct. 30 2008
Extra navigation
VEGF on the brain
by Tim Fulmer, Senior Writer
Belgian scientists suggest that VEGF-B may be used to treat neurodegenerative diseases and may provide a less angiogenic alternative to the VEGF-A they are already developing for ALS with NeuroNova AB.
To read this article in full you will need to log-in or choose from the options on the right.
